Date Modified

2024-05-26

Period

12/months

Report Summary

• Trial commenced on 24.05.2023; • Recruitment status: recruiting; • Number assessed for eligibility: 75; • Number recruited and allocated/randomized: 63; • Final sample size: Target is 79 patients (including 10% dropouts).

Attached file